Antibodies Industry To Unlock Healthcare's Next FrontierPosted by Jyoti on January 9th, 2024 ![]() Global antibodies industry data book is a collection of market sizing information & forecasts, regulatory data, competitive benchmarking analyses, macro-environmental analyses, and technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research. The antibodies industry data book is a combination of the market data from seven reports namely, antibodies production, polyclonal antibodies, monoclonal antibodies, cancer monoclonal antibodies, research antibodies, custom antibodies, and mammalian polyclonal IgG antibodies market. Antibody Production Market Growth & Trends The antibodies industry has observed tremendous growth in the last couple of decades. There has been continuous advancement in the manufacturing technologies that are being implemented in producing these novel biologics. With the discovery of applications of polyclonal and monoclonal antibodies for research purposes as well as therapeutic purposes, the demand for antibodies production has increased exponentially. A large number of companies as well as CDMOs are involved in the manufacturing of antibodies at the commercial scale. The use of single-use technology such as single-use assemblies and single-use bioreactors has also played a crucial role in reducing the processing cost and boosting the production scale, thus pushing the antibodies production market growth. With major pharmaceutical key players investing in the manufacturing processes, the global market for antibodies production is likely to exhibit exponential growth in the forthcoming years. The outbreak of COVID-19 has created lucrative opportunities in this business. Several leading pharmaceutical companies are investing heavily in R&D to create brand-new vaccinations, treatments, and testing tools for this pandemic. The need for antibodies production has greatly increased as a result of these intense R&D operations for the development of novel therapeutics. Additionally, a number of public and commercial entities are making significant efforts to fund the development of COVID-19 vaccines and therapeutics. For instance, in April 2020, Emergent BioSolutions, a biopharmaceutical company, received USD 14.5 million from the federal government to work on an antibodies therapy study for COVID-19. Monoclonal Antibodies Market Analysis & Forecast
Research Antibodies Market Analysis & Forecast
Order your copy of Free Sample of “Antibodies Industry Data Book - Antibodies Production, Polyclonal Antibody, Monoclonal Antibody, Cancer Monoclonal Antibody, Research Antibody, Custom Antibody, Mammalian IgG Polyclonal Antibody Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research Competitive Landscape
Like it? Share it!More by this author |